Crestline Management’s Janux Therapeutics JANX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-23,414
Closed -$1.25M 331
2024
Q4
$1.25M Buy
+23,414
New +$1.25M 0.04% 369